JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

EGFR

A8367 AST-1306

Summary: EGFR/HER2 inhibitor

≥22.45 mg/mL
A8366 ARRY-380

Target: HER2

Summary: Tyrosine kinase HER2 and p95-HER2 inhibitor

≥28.5 mg/mL
A8365 Varlitinib (ARRY334543)

Summary: ErbB inhibitor

≥23.35 mg/mL
A8357 AG-1478

Target: EGFR

Summary: EGFR inhibitor,potent and selective

insoluble in H2O; ≥15.8 mg/mL
A8322 Neratinib (HKI-272)
3 Citation

Target: EGFR

Summary: HER2/EGFR inhibitor,potent and irreversible

insoluble in H2O; ≥13.93 mg/mL
A8319 Dacomitinib (PF299804, PF299)

Target: ErbB

Summary: HER inhibitor

≥23.5 mg/mL
A8247 Afatinib (BIBW2992)
1 Citation

Target: EGFR

Summary: Irreversible EGFR/HER2 inhibitor

≥24.3 mg/mL
A8234 Erlotinib Hydrochloride
2 Citation

Summary: Selective EGFR inhibitor

insoluble in H2O; insoluble in EtOH; ≥6.44 mg/mL
A8219 Gefitinib (ZD1839)
15 Citation

Target: EGFR

Summary: Selective EGFR inhibitor

≥22.34 mg/mL
A8218 Lapatinib
7 Citation

Target: ErbB

Summary: EGFR/HER2 inhibitor,potent,selective and reversible

≥29.05 mg/mL